ConCensis Live Event | AAMI ST91

The upcoming episode of the ConCensis Podcast, presented by Censis Technologies, promises to be both enlightening and essential for healthcare professionals. Host Gabrielle Bejarano announces that on June 9th at 11 AM CT, the podcast will delve into crucial issues surrounding healthcare-acquired infections, sterilization, and quality control processing, all in alignment with the updated ST-91 guidelines. The episode will feature thought-provoking discussions with Kelly Swails from Censis Technologies and Dr. Mary Ann Drosnock from Healthmark Industries. They will explore the challenges in endoscope reprocessing and the pivotal role of electronic tracking systems in ensuring patient safety. This live stream event is a must-attend for those seeking to stay informed, maintain compliance, and enhance their professional knowledge in the healthcare industry. Don’t miss out on this opportunity to gain valuable insights and expertise. See you there!

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…